Cubist Systematic Strategies, LLC Oncternal Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $17.3 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.7 - $1.56 $13,933 - $31,051
-19,905 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$1.37 - $2.43 $27,269 - $48,369
19,905 New
19,905 $28,000
Q3 2021

Nov 15, 2021
SELL
$3.37 - $4.76 $68,411 - $96,628
-20,300 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$4.75 - $9.39 $88,012 - $173,987
-18,529 Reduced 47.72%
20,300 $96,000
Q1 2021

May 17, 2021
BUY
$4.59 - $9.04 $178,225 - $351,014
38,829 New
38,829 $323,000

Others Institutions Holding ONCT

# of Institutions
4
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $422M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email